Novartis AG vs Tapestry, Inc. — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Tapestry, Inc. trades at $140.62 (market cap $28.51B). The key difference: Novartis AG is far larger — about 10.2× Tapestry, Inc.'s market cap, and Novartis AG pays the higher dividend (3.17%). Which is the better fit depends on your goals.
| NVS | TPR | |
|---|---|---|
Market Cap | $290.25B | $28.51B |
Sector | Health | Consumer Cyclical |
52-Week High | $168.62 | $160.49 |
52-Week Low | $113.50 | $95.69 |
Enterprise Value | $330.27B | $31.37B |
Dividend Yield | 3.17% | 1.13% |
Trailing returns across standard periods
Latest headlines on both assets
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →Coach, Kate Spade, and Stuart Weitzman are the fashion and accessory brands that comprise Tapestry. The firm's products are sold through about 1,400 company-operated stores, wholesale channels, and e-commerce in North America (67% of fiscal 2022 sales), Europe, Asia (28% of fiscal 2022 sales), and elsewhere. Coach (74% of fiscal 2022 sales) is best known for affordable luxury leather products. Kate Spade (22% of fiscal 2022 sales) is known for colorful patterns and graphics. Women's handbags and accessories produced 69% of Tapestry's sales in fiscal 2022. Stuart Weitzman, Tapestry's smallest brand, generates nearly all its revenue from women's footwear.
Read more on TPR →